Literature DB >> 17376921

Poly(I:C) and lipopolysaccharide innate sensing functions of circulating human myeloid dendritic cells are affected in vivo in hepatitis C virus-infected patients.

Ian Gaël Rodrigue-Gervais1, Loubna Jouan, Geneviève Beaulé, Dominike Sauvé, Julie Bruneau, Bernard Willems, Rafick-Pierre Sékaly, Daniel Lamarre.   

Abstract

The role of peripheral dendritic cells (DCs) in hepatitis C virus (HCV) infection is unclear. To determine if persistent infection exerts an inhibitory pressure on HCV-specific innate responses, we analyzed DC function in blood through quantification of cell-associated HCV RNA levels in conjunction with multiparametric flow cytometry analysis of pathogen recognition receptor-induced cytokine expression. Independently of the serum viral load, fluorescence-activated cell sorter-purified total DCs had a wide range of cell-associated HCV genomic RNA copy numbers (mean log(10), 5.0 per 10(6) cells; range, 4.3 to 5.8). Here we report that for viremic patients with high viral loads in their total DCs, the myeloid DC (MDC) subset displayed impaired expression of interleukin-12 (IL-12) and tumor necrosis factor alpha (TNF-alpha) but normal IL-6 or chemokine CCL3 expression in response to poly(I:C) and lipopolysaccharide (LPS). IL-6-expressing cells from this subgroup of viremic patients demonstrated a significant increase (sixfold more) in TNF-alpha(-) IL-12(-) cell frequency compared to healthy donors (mean, 38.8% versus 6.5%; P < 0.0001), indicating a functional defect in a subpopulation of cytokine-producing MDCs ( approximately 6% of MDCs). Attenuation of poly(I:C) and LPS innate sensing was HCV RNA density dependent and did not correlate with viremia or deficits in circulating MDC frequencies in HCV-infected patients. Monocytes from these patients were functionally intact, responding normally on a per-cell basis following stimulation, independent of cell-associated HCV RNA levels. Taken together, these data indicate that detection of HCV genomic RNA in DCs and loss of function in the danger signal responsiveness of a small proportion of DCs in vivo are interrelated rather than independent phenomena.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17376921      PMCID: PMC1900294          DOI: 10.1128/JVI.01741-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Toll-like receptors control activation of adaptive immune responses.

Authors:  M Schnare; G M Barton; A C Holt; K Takeda; S Akira; R Medzhitov
Journal:  Nat Immunol       Date:  2001-10       Impact factor: 25.606

2.  In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens.

Authors:  Steffen Jung; Derya Unutmaz; Phillip Wong; Gen-Ichiro Sano; Kenia De los Santos; Tim Sparwasser; Shengji Wu; Sri Vuthoori; Kyung Ko; Fidel Zavala; Eric G Pamer; Dan R Littman; Richard A Lang
Journal:  Immunity       Date:  2002-08       Impact factor: 31.745

3.  Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease.

Authors:  Eileen Foy; Kui Li; Chunfu Wang; Rhea Sumpter; Masanori Ikeda; Stanley M Lemon; Michael Gale
Journal:  Science       Date:  2003-04-17       Impact factor: 47.728

4.  Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairment.

Authors:  Christine Rollier; Joost A R Drexhage; Babs E Verstrepen; Ernst J Verschoor; Ronald E Bontrop; Gerrit Koopman; Jonathan L Heeney
Journal:  Hepatology       Date:  2003-10       Impact factor: 17.425

5.  Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.

Authors:  L Alexopoulou; A C Holt; R Medzhitov; R A Flavell
Journal:  Nature       Date:  2001-10-18       Impact factor: 49.962

6.  Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.

Authors:  Masahiro Yamamoto; Shintaro Sato; Hiroaki Hemmi; Katsuaki Hoshino; Tsuneyasu Kaisho; Hideki Sanjo; Osamu Takeuchi; Masanaka Sugiyama; Masaru Okabe; Kiyoshi Takeda; Shizuo Akira
Journal:  Science       Date:  2003-07-10       Impact factor: 47.728

7.  Identification of Lps2 as a key transducer of MyD88-independent TIR signalling.

Authors:  K Hoebe; X Du; P Georgel; E Janssen; K Tabeta; S O Kim; J Goode; P Lin; N Mann; S Mudd; K Crozat; S Sovath; J Han; B Beutler
Journal:  Nature       Date:  2003-07-20       Impact factor: 49.962

8.  Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR.

Authors:  Stefan Pöhlmann; Jie Zhang; Frédéric Baribaud; Zhiwei Chen; George J Leslie; George Lin; Angela Granelli-Piperno; Robert W Doms; Charles M Rice; Jane A McKeating
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

9.  Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection.

Authors:  Nadège Goutagny; Ahmed Fatmi; Victor De Ledinghen; François Penin; Patrice Couzigou; Geneviève Inchauspé; Christine Bain
Journal:  J Infect Dis       Date:  2003-05-29       Impact factor: 5.226

10.  Mycobacteria target DC-SIGN to suppress dendritic cell function.

Authors:  Teunis B H Geijtenbeek; Sandra J Van Vliet; Estella A Koppel; Marta Sanchez-Hernandez; Christine M J E Vandenbroucke-Grauls; Ben Appelmelk; Yvette Van Kooyk
Journal:  J Exp Med       Date:  2003-01-06       Impact factor: 14.307

View more
  20 in total

1.  Regulation of host innate immunity by hepatitis C virus: crosstalk between hepatocyte and NK/DC.

Authors:  Sung-Jae Park; Young S Hahn
Journal:  Rev Infect       Date:  2010-07-01

2.  Preserved MHC-II antigen processing and presentation function in chronic HCV infection.

Authors:  D H Canaday; C J Burant; L Jones; H Aung; L Woc-Colburn; D D Anthony
Journal:  Cell Immunol       Date:  2010-10-16       Impact factor: 4.868

Review 3.  The tug-of-war between dendritic cells and human chronic viruses.

Authors:  Saifur Rahman; Zafar K Khan; Pooja Jain
Journal:  Int Rev Immunol       Date:  2011 Oct-Dec       Impact factor: 5.311

4.  Potential confusion of contaminating CD16+ myeloid DCs with anergic CD16+ NK cells in chimpanzees.

Authors:  R Keith Reeves; Tristan I Evans; Patricia N Fultz; R Paul Johnson
Journal:  Eur J Immunol       Date:  2011-03-01       Impact factor: 5.532

Review 5.  A look behind closed doors: interaction of persistent viruses with dendritic cells.

Authors:  Mélanie Lambotin; Sukanya Raghuraman; Françoise Stoll-Keller; Thomas F Baumert; Heidi Barth
Journal:  Nat Rev Microbiol       Date:  2010-04-07       Impact factor: 60.633

6.  Hepatitis C and innate immunity: recent advances.

Authors:  Gyongyi Szabo; Angela Dolganiuc
Journal:  Clin Liver Dis       Date:  2008-08       Impact factor: 6.126

Review 7.  Innate and Adaptive Immune Responses in Chronic HCV Infection.

Authors:  Lynn B Dustin
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

8.  Sustained hyperresponsiveness of dendritic cells is associated with spontaneous resolution of acute hepatitis C.

Authors:  Sandy Pelletier; Nathalie Bédard; Elias Said; Petronela Ancuta; Julie Bruneau; Naglaa H Shoukry
Journal:  J Virol       Date:  2013-04-10       Impact factor: 5.103

Review 9.  Natural killer cells: multifaceted players with key roles in hepatitis C immunity.

Authors:  Lucy Golden-Mason; Hugo R Rosen
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

10.  Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells.

Authors:  Svetlana Marukian; Christopher T Jones; Linda Andrus; Matthew J Evans; Kimberly D Ritola; Edgar D Charles; Charles M Rice; Lynn B Dustin
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.